Fisher Wallace Laboratories
The Fisher Wallace Stimulator is a wearable neurostimulation device that is FDA Cleared to treat depression, anxiety, insomnia and chronic pain. Patients use the device at home or in a hospital or clinic setting, once or twice a day for 20 minutes. The device has been proven safe and effective in multiple published studies and if often used as an adjunct to medication. Over 6000 healthcare providers have prescribed the device in the U.S. since 2009. The device may be sold over the counter in Europe and Canada.
The device is currently used by hospitals, rehab clinics and in thousands of private practices. Low risk, high efficacy device offers institutional and individual customers a compelling treatment alternative for depression, anxiety, insomnia and chronic pain. Robust wholesale margins allow for strong profit potential.
Founded in 2007, Fisher Wallace Labs is a medium sized (over $5 million in sales) medical device company headquartered in NY with manufacturing in NJ. Regularly featured as an Inc 5000 company, the flagship product, the Fisher Wallace Stimulator, was named by Forbes magazine as "one of four technologies innovating mental health in 2016."